Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Miromatrix Medical Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q4 2021
- Shares held
- 3.18M
- +93.5K (+3.0%) vs. Q4 2021
- Total value
- $12.6M
- −$1.88M (−13.0%) vs. Q4 2021
- New holders
- 6
- 8 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 32 | $8.78M |
| Q2 2023 | 32 | $11.6M |
| Q1 2023 | 31 | $11.1M |
| Q4 2022 | 28 | $11.2M |
| Q3 2022 | 22 | $15.4M |
| Q2 2022 | 22 | $12.9M |
| Q1 2022 | 21 | $12.6M |
| Q4 2021 | 22 | $14.5M |
| Q3 2021 | 19 | $22.0M |
| Q2 2021 | 21 | $39.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Miromatrix Medical Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gagnon Securities LLC | 849,113 | $3.36M | 0.55% | +440,726+107.9% | Added |
| G2 Investment Partners Management LLC | 593,304 | $2.35M | 0.56% | −91,674−13.4% | Reduced |
| First Light Asset Management, LLC | 512,307 | $2.03M | 0.18% | +24,215+5.0% | Added |
| Gagnon Advisors, LLC | 459,604 | $1.82M | 0.84% | +229,802+100.0% | Added |
| RTW Investments, LP | 280,000 | $1.11M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 169,866 | $673.0K | 0.00% | +15,490+10.0% | Added |
| Stillwater Investment Management, LLC | 90,146 | $357.0K | 0.09% | +90,146 | New |
| Cambridge Investment Research Advisors, Inc. | 68,400 | $271.0K | 0.00% | +32,000+87.9% | Added |
| BlackRock Inc. | 30,139 | $119.0K | 0.00% | +14,958+98.5% | Added |
| Commonwealth Equity Services, LLC | 26,669 | $105.0K | 0.00% | +26,669 | New |
| State Street Corp | 23,417 | $93.0K | 0.00% | +23,417 | New |
| Perkins Capital Management Inc | 21,880 | $87.0K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 21,670 | $85.0K | 0.00% | +9,860+83.5% | Added |
| Ulland Investment Advisors, LLC | 12,000 | $48.0K | 0.04% | +12,000 | New |
| US Bancorp | 10,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,255 | $9.00K | 0.00% | +1,903+540.6% | Added |
| Royal Bank of Canada | 2,000 | $8.00K | 0.00% | −8,000−80.0% | Reduced |
| Morgan Stanley | 1,507 | $6.00K | 0.00% | +1,507 | New |
| Tower Research Capital LLC (TRC) | 1,288 | $5.00K | 0.00% | −1,297−50.2% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | +200 | New |
| Wells Fargo & Company | 41 | $0 | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −250,451−100.0% | Sold out |
| Friess Associates LLC | 0 | $0 | 0.00% | −246,323−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −177,642−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −15,821−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,013−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,212−100.0% | Sold out |
| Sweet Financial Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |